October 28, 2021: NCHR comments on the proposed PDUFA VII Commitment Letter from the FDA.
Read More »Tag: Drugs
Drug Prices Are One Focus of Biden’s Push to Boost Competition
Wall Street Journal, July 9, 2021: Drug prices in the US are extremely high with both sides of the aisle advocating for Medicare to be able to negotiate drug prices. Dr. Diana Zuckerman spoke with the WSJ about how President Biden plans to lower drug prices.
Read More »NCHR Statement Regarding Cancer Drugs that Failed to Confirm Efficacy after Accelerated Approval
April 29, 2021: Patients are being harmed when the FDA does not follow the law pertaining to FDA approval. Drugs must be proven safe and effective, and companies must continue randomized clinical trials that prove the benefits of their drugs outweigh the risks for most patients.
Read More »Coronavirus Relief Act Gives Drug Makers New Sway Over FDA
Pogo, May 5, 2020. Under the $2 trillion coronavirus relief law, makers of over-the-counter drugs will pay the FDA to oversee their products and will gain new sway over the consumer protection agency.
Read More »Medical Professors are Supposed to Share Their Outside Income With the University of California. But Many Don’t.
ProPublica, December 6, 2019. A comparison of University of California filings with federal data shows that moonlighting professors are shortchanging taxpayers.
Read More »